Work

Extended duration of anti-PD-1 therapy, using reduced frequency dosing, in patients with advanced melanoma and Merkel cell carcinoma.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.2588

Authors: Lisa May Ling Tachiki, Karly Williams Silva, Daniel S Hippe, Dane Fritzsche, Aleksandra Raczka, Andrea Perdue, Julia Majovski, Alexandra Spallone, Daniel A Goldstein, Paul Nghiem, John A. Thompson, Evan Thomas Hall, Shailender Bhatia

Institutions: University of Washington, Fred Hutch Cancer Center, Seattle Cancer Care Alliance, Rabin Medical Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W4281944617

Cites:

Cited by: 4

Related to: 10